InvestorsHub Logo
Followers 8
Posts 1500
Boards Moderated 0
Alias Born 07/22/2013

Re: gold007_2000 post# 79251

Thursday, 08/30/2018 12:42:04 AM

Thursday, August 30, 2018 12:42:04 AM

Post# of 108191
Everything for us the shareholders depends on how well NEO works. Were at the mercy of how well our NEO works with our LM platform. If we have results equal to Car-T or better then watch out because HOT is in the wings and Amgen can't allow others to cash in on that . Just my opinion though it seems Amgen wants to see results on 1st patient dosed and then decide if they are willing to bite the bullet if not that's fine too . Chess game going on ... question is who is going to blink 1st? I'm not scared of more dilution even down at $1.50 we can continue into 2019 and make some more deals as more data is forthcoming with NEO. To me it's all about our LM platform. It has shown great efficacy and safety for over the last 11 years! No reason to push for a sale of Advaxis when we've waited this long. Either you believe or you don't ... proof is coming and right fast! This journey is going to get crazy in the next year! Boom or Bust I'm here till the fat ass lady sings and I'm hoping she very hoarse! Dilution is a mute point if...if NEO becomes the shit! I'm in NO hurry to sell out until our NEO and HOT show results then if we have the goods ...Start the freakin bidding my friends! It won't be as cheap as Cat-T deals . We all know what they spent for those deals! Do you believe in our LM platform? That's what it all boiles down too! Others are working on NEO but with different platforms. Apples and Oranges being trialed right now , who's going to have the best platform that does the best job? I'm not sure but I'm pretty sure if we show great results we will have Tutes piling in by the boatloads! If not we go home empty handed and peddling our wares on pink sheets!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News